First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.

MLA

van der Meer, Pim B., et al. “First-Line Antiepileptic Drug Treatment in Glioma Patients with Epilepsy: Levetiracetam vs Valproic Acid.” Epilepsia, vol. 62, no. 5, May 2021, pp. 1119–29. EBSCOhost, https://doi.org/10.1111/epi.16880.

APA

van der Meer, P. B., Dirven, L., Fiocco, M., Vos, M. J., Kouwenhoven, M. C. M., van den Bent, M. J., Taphoorn, M. J. B., & Koekkoek, J. A. F. (2021). First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid. Epilepsia, 62(5), 1119–1129. https://doi.org/10.1111/epi.16880

Chicago

van der Meer, Pim B, Linda Dirven, Marta Fiocco, Maaike J Vos, Mathilde C M Kouwenhoven, Martin J van den Bent, Martin J B Taphoorn, and Johan A F Koekkoek. 2021. “First-Line Antiepileptic Drug Treatment in Glioma Patients with Epilepsy: Levetiracetam vs Valproic Acid.” Epilepsia 62 (5): 1119–29. doi:10.1111/epi.16880.